首页> 外国专利> Anti-Human Immunodeficiency Virus Surrogate Target Agent Technology Filter Intended to Neutralize or Remove Human Immunodeficiency Virus Virions From Blood

Anti-Human Immunodeficiency Virus Surrogate Target Agent Technology Filter Intended to Neutralize or Remove Human Immunodeficiency Virus Virions From Blood

机译:抗人类免疫缺陷病毒替代目标代理技术过滤器旨在中和或消​​除血液中的人类免疫缺陷病毒病毒

摘要

The Human Immunodeficiency Virus posses a significant threat to the world's population. Current strategies utilized to treat infectious agents have not been adequate to contain and eradicate this deadly viral infection. HIV seeks out its host, a T-Helper cell, by utilizing glycoprotein 120 probes to engage a CD4 cell-surface receptor located on the surface of a T-Helper cell. Developing blood filtering techniques that incorporate filter mediums that offer HIV virion's probes the opportunity to engage the cell-surface receptors they are seeking offers a means of neutralizing and removing HIV. Filtering the blood of a patient with filter mediums comprised of T-Helper cells, sheets of lipid bilayer or virus-like structures with each type of medium possessing cell-surface receptors intended to attract and engage HIV virions provides an effective strategy to prevent and treat AIDS.
机译:人类免疫缺陷病毒对世界人口构成重大威胁。目前用于治疗传染病的策略不足以遏制和根除这种致命的病毒感染。 HIV通过利用糖蛋白120探针与位于T辅助细胞表面的CD4细胞表面受体结合来寻找其宿主T辅助细胞。开发包含过滤介质的血液过滤技术,该过滤介质可为HIV virion的探针提供接触所寻求的细胞表面受体的机会,从而提供了一种中和和清除HIV的方法。用由T-Helper细胞,脂质双层或病毒样结构组成的过滤介质过滤患者的血液,每种类型的介质都具有旨在吸引和接合HIV病毒粒子的细胞表面受体,从而提供了有效的策略来预防和治疗艾滋病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号